Lebwohl, David
University of Auckland · St George's, University of London · The Royal Free Hospital · Auckland City Hospital · Intellia Therapeutics (United States) · University College London
6 papers on CoChatORCID 0000-0002-4578-1977
Most cited papers
- Verified
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine
CAR-T cell therapy researchAcute Lymphoblastic Leukemia research
Cited by 5,735
- Verified
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
Motzer, R. J., Escudier, B., Oudard, S., Hutson, T. E., Porta, C., Bracarda, S., Grünwald, V., Thompson, J. A., Figlin, R. A., Hollaender, N., et al. (2008) · The Lancet
Renal cell carcinoma treatmentBladder and Urothelial Cancer Treatments
Cited by 3,019
- Verified
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
Baselga, J., Campone, M., Piccart, M., Burris, H. A., Rugo, H. S., Sahmoud, T., Noguchi, S., Gnant, M., Pritchard, K. I., Lebrun, F., et al. (2012) · New England Journal of Medicine
Advanced Breast Cancer TherapiesPI3K/AKT/mTOR signaling in cancer
Cited by 2,863
- Verified
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Gillmore, J. D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M. L., Seitzer, J., O’Connell, D., Walsh, K. R., Wood, K., et al. (2021) · New England Journal of Medicine
Amyloidosis: Diagnosis, Treatment, OutcomesCRISPR and Genetic Engineering
Cited by 1,801
- Verified
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Franz, D. N., Belousova, E., Sparagana, S., Bebin, E. M., Frost, M., Kuperman, R., Witt, O., Kohrman, M. H., Flamini, J. R., Wu, J. Y., et al. (2013) · The Lancet
Tuberous Sclerosis Complex ResearchPI3K/AKT/mTOR signaling in cancer
Cited by 794
- Verified
Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin.
Chou, C. K., Dull, T. J., Russell, D. S., Gherzi, R., Lebwohl, D., Ullrich, A., & Rosen, O. M. (1987) · Journal of Biological Chemistry
Metabolism, Diabetes, and CancerProtein Kinase Regulation and GTPase Signaling
Cited by 640
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free